-
1
-
2
-
3
1005 BiXAb® MAIT Engagers: solving the problems of classical T-cell engagers in the treatment of solid tumors
Published 2023-11-01Article -
4
-
5
-
6
-
7
Vdelta1 T cells are more resistant than Vdelta2 T cells to the immunosuppressive properties of galectin-3
Published 2024-01-01Get full text
Article -
8
Oncogenic KRAS Impairs EGFR Antibodies' Efficiency by C/EBPβ-Dependent Suppression of EGFR Expression
Published 2012-03-01Get full text
Article -
9
Minimal B Cell Extrinsic IgG Glycan Modifications of Pro- and Anti-Inflammatory IgG Preparations in vivo
Published 2020-01-01Get full text
Article -
10